From COVID-19 vaccines to Moderna’s mRNA flu vaccine, using mRNA as medicine has shown promise. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.
Articles on mRNA vaccines
Displaying 1 - 20 of 112 articles
This latest trial hopes to test the vaccine in people who are most at risk of acquiring bird flu.
Canada must decide what kind of country it wants to be: One that generates new scientific knowledge, or one that waits for other nations’ discoveries.
False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a promising tool to prevent and treat it.
After pushback, the agency reversed course and agreed to review Moderna’s application after all.
The move signals an escalation in the agency’s efforts to interfere with established procedures for testing and approving vaccines.
The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to traditional immunotherapy.
Chaos at the CDC and the sharp move away from mRNA vaccines has public health experts alarmed.
Vaccines saved 154 million lives. But as fear of disease fades, so does protection – raising the chilling prospect of a return to the pre-vaccine era.
Viruses mutate all the time. Vaccines don’t cause this – they help filter which strains survive.
Australian livestock farmers see foot-and-mouth disease as an existential threat. A new vaccine offers hope – but not a silver bullet.
The Advisory Committee on Immunization Practices guides the CDC’s hand on vaccine policy, but some of its new members have voiced anti-vaccine views.
One of the cornerstones of being prepared for the next pandemic is being in the best position possible to design and deploy a suitable vaccine.
Could mRNA vaccines be the next big thing for melanoma?
AstraZeneca withdrawing it COVID vaccine from the market has nothing to do with blood clots.
Cancer vaccines have gained much interest among scientists but face a number of hurdles. A new mRNA vaccine for glioma offers a step forward in training the immune system to fight cancer.
The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.
mRNA vaccines are very safe, but this problem needed to be fixed for future mRNA therapies.
From COVID-19 vaccines to cancer treatments and beyond, the flexibility of mRNA-based therapies gives them the potential to prevent and treat many types of diseases.
Considered a pipe dream not too long ago, research on RNA therapeutics is progressing rapidly. Now a new manufacturing protocol will help researchers to advance the technology.
Top contributors
-
Associate Professor and ARC Future Fellow, The University of Western Australia
-
Professor of Microbiology, School of Medicine, University of Washington
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Pediatric Infectious Diseases Fellow, University of Pittsburgh
-
Professor of Medicine, University of Virginia
-
Associate Professor of Biology, Rochester Institute of Technology
-
Senior Research Fellow in Global Health, University of Southampton
-
Bioengineer and Research Fellow, Monash University
-
Australia's Chief Scientist, Office of the Chief Scientist
-
Early Career Research Leader, Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University
-
Professor and Department Chair of Infectious Diseases and Microbiology, University of Pittsburgh
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Biomedical Sciences, Anglia Ruskin University